2023
DOI: 10.1016/j.ejphar.2023.175490
|View full text |Cite
|
Sign up to set email alerts
|

Comparison of the effects of peficitinib and tofacitinib in the adjuvant-induced arthritis rat model

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 35 publications
0
1
0
Order By: Relevance
“…The JAK pathway is triggered by various pro-inflammatory cytokines and the pathway in turn results in the production of more cytokines and this vicious cycle contributes to the severity of the disease. This was supported by observing the reduction in disease severity and joint destruction on treatment with JAK inhibitors like tofacitinib and peficitinib (Ishikawa et al, 2023). The profusion of cytokines that are circulated during RA advancement is perceived by nociceptive receptors and this phenomenon induces the sensation of pain.…”
Section: Jak-signal Transducer and Activator Of Transcription Pathwaymentioning
confidence: 90%
“…The JAK pathway is triggered by various pro-inflammatory cytokines and the pathway in turn results in the production of more cytokines and this vicious cycle contributes to the severity of the disease. This was supported by observing the reduction in disease severity and joint destruction on treatment with JAK inhibitors like tofacitinib and peficitinib (Ishikawa et al, 2023). The profusion of cytokines that are circulated during RA advancement is perceived by nociceptive receptors and this phenomenon induces the sensation of pain.…”
Section: Jak-signal Transducer and Activator Of Transcription Pathwaymentioning
confidence: 90%